HealthDay - THURSDAY, Sept. 30 (HealthDay News) -- New research finds that women with ovarian cancer relapse who start chemotherapy as soon as levels of a biomarker for the cancer rise don't live significantly longer than women who wait until symptoms begin to reappear.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.